Atlas Trials

Sarfez Pharmaceuticals, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sarfez Pharmaceuticals, Inc.

RecordFirmDate
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease (NCT07223502)Sarfez Pharmaceuticals, Inc.2025-12-01
Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects (NCT07015671)Sarfez Pharmaceuticals, Inc.2025-07-01
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects (NCT07043634)Sarfez Pharmaceuticals, Inc.2025-06-15
Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone (NCT07046975)Sarfez Pharmaceuticals, Inc.2025-06-15
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure (NCT06995144)Sarfez Pharmaceuticals, Inc.2025-05-28
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs (NCT06708611)Sarfez Pharmaceuticals, Inc.2025-01-15
Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal (NCT06176794)Sarfez Pharmaceuticals, Inc.2024-11-15
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder (NCT06206512)Sarfez Pharmaceuticals, Inc.2024-06-15
Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide (NCT03509545)Sarfez Pharmaceuticals, Inc.2021-06-30
A Food Effect Study of 60mg ER Torsemide (NCT03215875)Sarfez Pharmaceuticals, Inc.2017-10-17

Track Sarfez Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.